HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired fibrinolytic activity is present in children with dyslipidemias.

Abstract
Dyslipidemias are major risk factors for atherosclerosis and cardiovascular disease. Abnormalities of fibrinolytic and coagulation components are considered useful predictors of cardiovascular morbidity and mortality in adults. This study examined whether fibrinolytic and coagulation components are abnormal in children with dyslipidemia. Thirty-six children with asymptomatic dyslipidemia, and 26 control subjects underwent venous occlusion stress testing with collection of preocclusion and postocclusion blood samples. All samples were assayed for tissue plasminogen activator, plasminogen, plasminogen activator inhibitor-1, alpha(2)-antiplasmin, alpha(2)-macroglobulin, D-dimer, fibrinogen, and von Willebrand factor. Children with dyslipidemia had significantly decreased levels of tissue plasminogen activator in both preocclusion and postocclusion samples compared with control subjects, reflecting decreased fibrinolytic activity. Children with dyslipidemia also had significantly increased levels of plasminogen, alpha(2)-macroglobulin, and fibrinogen in preocclusion and postocclusion samples compared with control subjects. In conclusion, decreased fibrinolytic activity is present in asymptomatic children with dyslipidemias, potentially reflecting endothelial dysfunction and increased risk of cardiovascular disease in early adult life. Further studies are required to determine the usefulness of this marker in predicting disease progression or response to therapy.
AuthorsManuela Albisetti, Anthony K C Chan, Brian W McCrindle, Derek Wong, Paul Monagle, Maureen Andrew
JournalPediatric research (Pediatr Res) Vol. 55 Issue 4 Pg. 576-80 (Apr 2004) ISSN: 0031-3998 [Print] United States
PMID14739372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Coagulation Factors
Topics
  • Adolescent
  • Adult
  • Blood Coagulation (physiology)
  • Blood Coagulation Factors (metabolism)
  • Cardiovascular Diseases (physiopathology)
  • Child
  • Female
  • Fibrinolysis (physiology)
  • Humans
  • Hyperlipidemias (metabolism)
  • Male
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: